London, UK, Friday 30 May 2025 – Today, AstraZeneca announced that the National Institute for Health and Care Excellence (NICE) has published updated Final Draft Guidance recommending Forxiga ...

Patients were randomly assigned to calorie restriction with dapagliflozin 10 mg/day or placebo ... The study was partially ...

The SGLT2 inhibitors, as a class, lead to similar treatment benefits at comparable clinical doses, although there are some discrepancies between them, particularly when dapagliflozin (Farxiga; ...

Dapagliflozin (Farxiga, AstraZeneca) received approval based ... insulin or both were randomly assigned to 5 mg or 10 mg dapagliflozin, 2.5 mg or 5 mg saxagliptin, or placebo as an add-on ...

After that, Heerspink's group only continued with part B of the trial: zibotentan 1.5 mg plus dapagliflozin 10 mg/day and zibotentan ... The trial was funded by AstraZeneca. Some co-authors ...

AstraZeneca Pharma India on Monday said it has received approval for extended indication from the Drugs Controller General of India for Dapagliflozin 10 mg tablets. The receipt of this permission ...

AstraZeneca Pharma India on Monday said it has received approval for extended indication from the Drugs Controller General of India for Dapagliflozin 10 mg tablets. The company has received permission ...

2.1 Dapagliflozin (Forxiga, AstraZeneca) is indicated in adults for 'the treatment ... in adults (NICE technology appraisal guidance 679). 2.4 The list price of 10 mg dapagliflozin is £36.59 per ...

Among patients who have heart failure with preserved ejection fraction (HFpEF), 24 weeks of treatment with dapagliflozin (Farxiga; AstraZeneca ... treatment with either placebo or dapagliflozin 10 mg ...

Dapagliflozin 10 mg once daily reduced the risk of the primary ... Disclosure: The DAPA-HF and DELIVER trials were funded by AstraZeneca. Please see the original reference for a full list of ...

Through this approval, the company is permitted to deal in Dapagliflozin (Forxiga) tablets of 10 mg in additional/expanded indication ... CV death and hHF. Astrazeneca Pharma India is engaged in the ...